NASDAQ:ARWR - Arrowhead Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$18.10 -0.03 (-0.17 %)
(As of 02/20/2019 04:00 PM ET)
Previous Close$18.13
Today's Range$17.66 - $18.54
52-Week Range$5.35 - $22.39
Volume1.40 million shs
Average Volume1.82 million shs
Market Capitalization$1.71 billion
P/E Ratio-27.85
Dividend YieldN/A
Beta2.23

Analyst Ratings

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Arrowhead Pharmaceuticals in the last 12 months. Their average twelve-month price target is $21.3633, suggesting that the stock has a possible upside of 18.03%. The high price target for ARWR is $25.00 and the low price target for ARWR is $11.68. There are currently 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.002.83
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $21.3633$21.3633$21.4467$16.1967
Price Target Upside: 18.03% upside49.19% upside54.63% upside4.10% downside

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Consensus Price Target History

Price Target History for Arrowhead Pharmaceuticals (NASDAQ:ARWR)

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/11/2019Chardan CapitalReiterated RatingBuy$24.50HighView Rating Details
12/11/2018Cantor FitzgeraldSet Price TargetBuy$24.00HighView Rating Details
10/17/2018William BlairReiterated RatingOutperformMediumView Rating Details
10/4/2018Piper Jaffray CompaniesReiterated RatingOverweight$25.00HighView Rating Details
9/14/2018Jefferies Financial GroupBoost Price TargetPositive ➝ Buy$24.00MediumView Rating Details
9/6/2018B. RileyUpgradeNeutral ➝ Buy$18.00 ➝ $19.00HighView Rating Details
6/18/2018S&P Equity ResearchLower Price Target$13.76 ➝ $11.68MediumView Rating Details
(Data available from 2/20/2017 forward)
This page was last updated on 2/20/2019 by MarketBeat.com Staff

Featured Article: How Short Selling Works

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel